Erik Haas

Johnson & Johnson proposes a $5.5 billion settlement to resolve remaining lawsuits alleging its talc products caused ovarian cancer, requiring 95% participation from claimants. The company previously rejected a $9 billion settlement proposal denied by a U.S. bankruptcy court and faces a federal judge's recent order dismissing claims lacking direct product-cancer links.

Johnson & Johnson proposes a $5.5 billion settlement to resolve remaining talc-related lawsuits claiming its products caused ovarian cancer. The settlement requires at least 95% participation from claimants and includes an initial $3 billion payment next year, with no further payments until 2028. The company previously settled most claims related to mesothelioma, consumer protection, and talc-supplier disputes.